CD38 deletion to preserve CAR T cell metabolism and promote functional persistence
Year: 2024
Type: article
Abstract: Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron, Immunity, Current Biology, AJHG, and the Trends Journals.
Source: Molecular Therapy Oncology
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,900
Awards: G1725776530, The EDRN Mesothelioma Biomarker Discovery Laboratory, G2051006376, G2272812018, G2277941041, G289723095, G3994034673, G8790735321, G9000003249, G9000041582, G9000096403, G9000140850, Cancer Center Support Grant, CD28-KITv CAR T cells with PD-1 dominant negative receptor, G954026598
OpenAlex ID: W4400601797